Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review)
- Authors:
- Shanhu Zhou
- Limin Tu
- Wei Chen
- Gangli Yan
- Hongmei Guo
- Xinhua Wang
- Qian Hu
- Huiqing Liu
- Fengguang Li
-
Affiliations: Department of Neurology, Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei 430081, P.R. China - Published online on: December 14, 2023 https://doi.org/10.3892/etm.2023.12351
- Article Number: 63
-
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Kovács Z, Brunner B and Ari C: Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases. Nutrients. 13(2197)2021.PubMed/NCBI View Article : Google Scholar | |
|
Jensen L, Monnat SM, Green JJ, Hunter LM and Sliwinski MJ: Rural population health and aging: Toward a multilevel and multidimensional research agenda for the 2020s. Am J Public Health. 110:1328–1331. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li Y, Xu H, Wang H, Yang K, Luan J and Wang S: TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease. Biomed Pharmacother. 165(115218)2023.PubMed/NCBI View Article : Google Scholar | |
|
Maria C and Rauter AP: Nucleoside analogues: N-glycosylation methodologies, synthesis of antiviral and antitumor drugs and potential against drug-resistant bacteria and Alzheimer's disease. Carbohydr Res. 532(108889)2023.PubMed/NCBI View Article : Google Scholar | |
|
Stocker H, Trares K, Beyer L, Perna L, Rujescu D, Holleczek B, Beyreuther K, Gerwert K, Schöttker B and Brenner H: Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years. Alzheimers Res Ther. 15(129)2023.PubMed/NCBI View Article : Google Scholar | |
|
Weller J and Budson A: Current understanding of Alzheimer's disease diagnosis and treatment. F1000Res 7: F1000 Faculty Rev-1161, 2018. | |
|
Ismail Z, Leon R, Creese B, Ballard C, Robert P and Smith EE: Optimizing detection of Alzheimer's disease in mild cognitive impairment: A 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO. Mol Neurodegener. 18(50)2023.PubMed/NCBI View Article : Google Scholar | |
|
Antoniou A, Stavrou M, Evripidou N, Georgiou E, Kousiappa I, Koupparis A, Papacostas SS, Kleopa KA and Damianou C: FUS-mediated blood-brain barrier disruption for delivering anti-Aβ antibodies in 5XFAD Alzheimer's disease mice. J Ultrasound: Jul 29, 2023 (Epub ahead of print). doi: 10.1007/s40477-023-00805-4. | |
|
Śliwińska S and Jeziorek M: The role of nutrition in Alzheimer's disease. Rocz Panstw Zakl Hig. 72:29–39. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Fan R, Peng X, Xie L, Dong K, Ma D, Xu W, Shi X, Zhang S, Chen J, Yu X, et al: Importance of Bmal1 in Alzheimer's disease and associated aging-related diseases. Mechanisms and interventions. Aging Cell. 21(e13704)2022.PubMed/NCBI View Article : Google Scholar | |
|
Carvalho C and Moreira PI: Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria. Curr Opin Neurobiol. 79(102694)2023.PubMed/NCBI View Article : Google Scholar | |
|
Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD and Giau VV: Type 3 diabetes and its role implications in Alzheimer's disease. Int J Mol Sci. 21(3165)2020.PubMed/NCBI View Article : Google Scholar | |
|
Janoutová J, Machaczka O, Zatloukalová A and Janout V: Is Alzheimer's disease a type 3 diabetes? A review. Cent Eur J Public Health. 30:139–143. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Kandimalla R, Thirumala V and Reddy PH: Is Alzheimer's disease a type 3 diabetes? A critical appraisal. Biochim Biophys Acta Mol Basis Dis. 1863:1078–1089. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Michailidis M, Moraitou D, Tata DA, Kalinderi K, Papamitsou T and Papaliagkas V: Alzheimer's disease as type 3 diabetes: Common pathophysiological mechanisms between Alzheimer's disease and type 2 diabetes. Int J Mol Sci. 23(2687)2022.PubMed/NCBI View Article : Google Scholar | |
|
Diniz Pereira J, Gomes Fraga V, Morais Santos AL, Carvalho MDG, Caramelli P and Braga Gomes K: Alzheimer's disease and type 2 diabetes mellitus: A systematic review of proteomic studies. J Neurochem. 156:753–776. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, et al: Brain insulin resistance in type 2 diabetes and Alzheimer disease: Concepts and conundrums. Nat Rev Neurol. 14:168–181. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hamzé R, Delangre E, Tolu S, Moreau M, Janel N, Bailbé D and Movassat J: Type 2 diabetes mellitus and Alzheimer's disease: Shared molecular mechanisms and potential common therapeutic targets. Int J Mol Sci. 23(15287)2022.PubMed/NCBI View Article : Google Scholar | |
|
Chen Z and Zhong C: Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies. Prog Neurobiol. 108:21–43. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Candasamy M, Mohamed Elhassan SA, Kumar Bhattamisra S, Hua WY, Sern LM, Binti Busthamin NA, Mohamad Ilni NB, Shun NS, Baohong L, Ya NS and Ying NW: Type 3 diabetes (Alzheimer's disease): New insight for promising therapeutic avenues. Panminerva Med. 62:155–163. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Huang NQ, Yan F, Jin H, Zhou SY, Shi JS and Jin F: Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link. Behav Brain Res. 339:57–65. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Moayedi K, Orandi S, Ebrahimi R, Tanhapour M, Moradi M, Abbastabar M and Golestani A: A novel approach to type 3 diabetes mechanism: The interplay between noncoding RNAs and insulin signaling pathway in Alzheimer's disease. J Cell Physiol. 237:2838–2861. 2022.PubMed/NCBI View Article : Google Scholar | |
|
de la Monte SM: The full spectrum of Alzheimer's disease is rooted in metabolic derangements that drive type 3 diabetes. Adv Exp Med Biol. 1128:45–83. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ma LY, Fei YL, Wang XY, Wu SD, Du JH, Zhu M, Jin L, Li M, Li HL, Zhai JJ, et al: The research on the relationship of RAGE, LRP-1, and Aβ accumulation in the hippocampus, prefrontal lobe, and amygdala of STZ-Induced diabetic rats. J Mol Neurosci. 62:1–10. 2017.PubMed/NCBI View Article : Google Scholar | |
|
XiaoMing Z, Xi Z, Fang S and Jilin Z: Specific changes of somatostatin mRNA expression in the frontal cortex and hippocampus of diabetic rats. J Anat. 204:221–225. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Lachmann G, Spies C, Windmann V, Wollersheim T, Engelhardt LJ, Winterer G and Kuehn S: BIOCOG Study Group. Impact of intraoperative hyperglycemia on brain structures and volumes. J Neuroimaging. 29:260–267. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Bao H, Liu Y, Zhang M, Chen Z, Zhang W, Ge Y, Kang D, Gao F and Shen Y: Increased β-site APP cleaving enzyme 1-mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment. Alzheimers Dement. 17:1097–1108. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Braun M, Ramracheya R and Rorsman P: Autocrine regulation of insulin secretion. Diabetes Obes Metab. 14 (Suppl 3):S143–S151. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Botteri G, Salvadó L, Gumà A, Lee Hamilton D, Meakin PJ, Montagut G, Ashford MLJ, Ceperuelo-Mallafré V, Fernández-Veledo S, Vendrell J, et al: The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling. Metabolism. 85:59–75. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang Q, Duan L, Li X, Wang Y, Guo W, Guan F and Ma S: Glucose metabolism, neural cell senescence and Alzheimer's disease. Int J Mol Sci. 23(4351)2022.PubMed/NCBI View Article : Google Scholar | |
|
Li H, Yang S, Wu J, Ji L, Zhu L, Cao L, Huang J, Jiang Q, Wei J, Liu M, et al: cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease. J Cell Biochem. 119:1616–1626. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Farr SA, Roesler E, Niehoff ML, Roby DA, McKee A and Morley JE: Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer's disease. J Alzheimers Dis. 68:1699–1710. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Mishra D, Reddy I and Dey CS: PKCα Isoform inhibits insulin signaling and aggravates neuronal insulin resistance. Mol Neurobiol. 60:6642–6659. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Oriente F, Andreozzi F, Romano C, Perruolo G, Perfetti A, Fiory F, Miele C, Beguinot F and Formisano P: Protein kinase C-alpha regulates insulin action and degradation by interacting with insulin receptor substrate-1 and 14-3-3 epsilon. J Biol Chem. 280:40642–40649. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Qi XM and Chen G: p38γ MAPK inflammatory and metabolic signaling in physiology and disease. Cells. 12(1674)2023.PubMed/NCBI View Article : Google Scholar | |
|
Esterline R, Oscarsson J and Burns J: A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease? Int Rev Neurobiol. 155:113–140. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, et al: Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 122:1316–1338. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Frith E and Loprinzi PD: Fitness Fatness Index and Alzheimer-specific mortality. Eur J Intern Med. 42:51–53. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Pugazhenthi S, Qin L and Reddy PH: Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis. 1863:1037–1045. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG and Carvalho MDG: Alzheimer's disease: Risk factors and potentially protective measures. J Biomed Sci. 26(33)2019.PubMed/NCBI View Article : Google Scholar | |
|
Flores-Cordero JA, Pérez-Pérez A, Jiménez-Cortegana C, Alba G, Flores-Barragán A and Sánchez-Margalet V: Obesity as a risk factor for dementia and Alzheimer's disease: The Role of Leptin. Int J Mol Sci. 23(5202)2022.PubMed/NCBI View Article : Google Scholar | |
|
Khanna D, Peltzer C, Kahar P and Parmar MS: Body mass index (BMI): A screening tool analysis. Cureus. 14(e22119)2022.PubMed/NCBI View Article : Google Scholar | |
|
Flegal KM, Kit BK, Orpana H and Graubard BI: Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA. 309:71–82. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Ashwell M, Gunn P and Gibson S: Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis. Obes Rev. 13:275–286. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Diehl-Wiesenecker E, von Armin CA, Dupuis L, Müller HP, Ludolph AC and Kassubek J: Adipose tissue distribution in patients with Alzheimer's disease: A whole body MRI Case-Control study. J Alzheimers Dis. 48:825–832. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Boccara E, Golan S and Beeri MS: The association between regional adiposity, cognitive function, and dementia-related brain changes: A systematic review. Front Med (Lausanne). 10(1160426)2023.PubMed/NCBI View Article : Google Scholar | |
|
Gómez-Apo E, Mondragón-Maya A, Ferrari-Díaz M and Silva-Pereyra J: Structural Brain Changes associated with overweight and obesity. J Obes. 2021(6613385)2021.PubMed/NCBI View Article : Google Scholar | |
|
Li X, Chen H, Lv Y, Chao HH, Gong L, Li CR and Cheng H: Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients. Sci Rep. 8(13801)2018.PubMed/NCBI View Article : Google Scholar | |
|
Miao Y, Zhang B, Sun X, Ma X, Fang D, Zhang W, Wu T, Xu X, Yu C, Hou Y, et al: The presence and severity of NAFLD are associated with cognitive impairment and hippocampal damage. J Clin Endocrinol Metab. 108:3239–3249. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Weinstein G, Zelber-Sagi S, Preis SR, Beiser AS, DeCarli C, Speliotes EK, Satizabal CL, Vasan RS and Seshadri S: Association of nonalcoholic fatty liver disease with lower brain volume in healthy Middle-aged adults in the framingham study. JAMA Neurol. 75:97–104. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ruchinskas R, Nguyen T, Womack K, Khera A, Yu FF and Kelley BJ: Diagnostic utility of hippocampal volumetric data in a memory disorder clinic setting. Cogn Behav Neurol. 35:66–75. 2022.PubMed/NCBI View Article : Google Scholar | |
|
van Oostveen WM and de Lange ECM: Imaging techniques in Alzheimer's disease: A review of applications in early diagnosis and longitudinal monitoring. Int J Mol Sci. 22(2110)2021.PubMed/NCBI View Article : Google Scholar | |
|
Prem Kumar A, Singh N, Nair D and Justin A: Neuronal PET tracers for Alzheimer's disease. Biochem Biophys Res Commun. 587:58–62. 2022.PubMed/NCBI View Article : Google Scholar | |
|
So SW, Fleming KM, Nixon JP and Butterick TA: Early life obesity increases neuroinflammation, amyloid beta deposition, and cognitive decline in a mouse model of Alzheimer's disease. Nutrients. 15(2494)2023.PubMed/NCBI View Article : Google Scholar | |
|
Jayaraman A, Lent-Schochet D and Pike CJ: Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function. J Neuroinflammation. 11(162)2014.PubMed/NCBI View Article : Google Scholar | |
|
Liu P, Wang ZH, Kang SS, Liu X, Xia Y, Chan CB and Ye K: High-fat diet-induced diabetes couples to Alzheimer's disease through inflammation-activated C/EBPβ/AEP pathway. Mol Psychiatry. 27:3396–3409. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Medrano-Jiménez E, Jiménez-Ferrer Carrillo I, Pedraza-Escalona M, Ramírez-Serrano CE, Álvarez-Arellano L, Cortés-Mendoza J, Herrera-Ruiz M, Jiménez-Ferrer E, Zamilpa A, Tortoriello J, et al: Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism. J Neuroinflammation. 16(143)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang B, Chen T, Cao M, Yuan C, Reiter RJ, Zhao Z, Zhao Y, Chen L, Fan W, Wang X, et al: Gut microbiota dysbiosis induced by decreasing endogenous melatonin mediates the pathogenesis of Alzheimer's disease and obesity. Front Immunol. 13(900132)2022.PubMed/NCBI View Article : Google Scholar | |
|
Obradovic M, Zaric B, Sudar-Milovanovic E, Ilincic B, Stokic E, Perovic M and Isenovic ER: PCSK9 and hypercholesterolemia: Therapeutic Approach. Curr Drug Targets. 19:1058–1067. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Mannarino MR, Ministrini S and Pirro M: Nutraceuticals for the treatment of hypercholesterolemia. Eur J Intern Med. 25:592–599. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Loera-Valencia R, Goikolea J, Parrado-Fernandez C, Merino-Serrais P and Maioli S: Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment. J Steroid Biochem Mol Biol. 190:104–114. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Appleton JP, Scutt P, Sprigg N and Bath PM: Hypercholesterolaemia and vascular dementia. Clin Sci (Lond). 131:1561–1578. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Sandebring-Matton A, Goikolea J, Björkhem I, Paternain L, Kemppainen N, Laatikainen T, Ngandu T, Rinne J, Soininen H, Cedazo-Minguez A, et al: 27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial. Alzheimers Res Ther. 13(56)2021.PubMed/NCBI View Article : Google Scholar | |
|
Reiman EM, Chen K, Langbaum JB, Lee W, Reschke C, Bandy D, Alexander GE and Caselli RJ: Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Neuroimage. 49:169–176. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Gottesman RF, Schneider AL, Zhou Y, Coresh J, Green E, Gupta N, Knopman DS, Mintz A, Rahmim A, Sharrett AR, et al: Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA. 317:1443–1450. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Serrano-Pozo A, Das S and Hyman BT: APOE and Alzheimer's disease: Advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20:68–80. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM and Bu G: ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias. Neuron. 110:1304–1317. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G and Liu CC: ApoE in Alzheimer's disease: Pathophysiology and therapeutic strategies. Mol Neurodegener. 17(72)2022.PubMed/NCBI View Article : Google Scholar | |
|
Koutsodendris N, Nelson MR, Rao A and Huang Y: Apolipoprotein E and Alzheimer's Disease: Findings, hypotheses, and potential mechanisms. Annu Rev Pathol. 17:73–99. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Lanfranco MF, Ng CA and Rebeck GW: ApoE lipidation as a therapeutic target in Alzheimer's disease. Int J Mol Sci. 21(6336)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhao N, Liu CC, Qiao W and Bu G: Apolipoprotein E, receptors, and modulation of Alzheimer's disease. Biol Psychiatry. 83:347–357. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Fernández-Calle R, Konings SC, Frontiñán-Rubio J, García-Revilla J, Camprubí-Ferrer L, Svensson M, Martinson I, Boza-Serrano A, Venero JL, Nielsen HM, et al: APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer's disease pathology and brain diseases. Mol Neurodegener. 17(62)2022.PubMed/NCBI View Article : Google Scholar | |
|
McNamara DJ: Dietary cholesterol, heart disease risk and cognitive dissonance. Proc Nutr Soc. 73:161–166. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Lee SB, Kim HG, Lee JS, Kim WY, Lee MM, Kim YH, Lee JO, Kim HS and Son CG: Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model. Am J Physiol Gastrointest Liver Physiol. 317:G811–G823. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ettcheto M, Petrov D, Pedrós I, Alva N, Carbonell T, Beas-Zarate C, Pallas M, Auladell C, Folch J and Camins A: Evaluation of neuropathological effects of a High-Fat diet in a presymptomatic Alzheimer's disease stage in APP/PS1 Mice. J Alzheimers Dis. 54:233–251. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Bromley-Brits K, Deng Y and Song W: Morris water maze test for learning and memory deficits in Alzheimer's disease model mice. J Vis Exp. 20(2920)2011.PubMed/NCBI View Article : Google Scholar | |
|
Song J: Animal model of aluminum-induced Alzheimer's disease. Adv Exp Med Biol. 1091:113–127. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Drummond E and Wisniewski T: Alzheimer's disease: Experimental models and reality. Acta Neuropathol. 133:155–175. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhang L, Chen C, Mak MS, Lu J, Wu Z, Chen Q, Han Y, Li Y and Pi R: Advance of sporadic Alzheimer's disease animal models. Med Res Rev. 40:431–458. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Thawkar BS and Kaur G: Zebrafish as a promising tool for modeling Neurotoxin-Induced Alzheimer's disease. Neurotox Res. 39:949–965. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Tsuda L and Lim YM: Alzheimer's disease model system using drosophila. Adv Exp Med Biol. 1076:25–40. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Souder DC, Dreischmeier IA, Smith AB, Wright S, Martin SA, Sagar MAK, Eliceiri KW, Salamat SM, Bendlin BB, Colman RJ, et al: Rhesus monkeys as a translational model for late-onset Alzheimer's disease. Aging Cell. 20(e13374)2021.PubMed/NCBI View Article : Google Scholar | |
|
Edler MK, Munger EL, Meindl RS, Hopkins WD, Ely JJ, Erwin JM, Mufson EJ, Hof PR, Sherwood CC and Raghanti MA: Neuron loss associated with age but not Alzheimer's disease pathology in the chimpanzee brain. Philos Trans R Soc Lond B Biol Sci. 375(20190619)2020.PubMed/NCBI View Article : Google Scholar | |
|
Dewey CW, Davies ES, Xie H and Wakshlag JJ: Canine cognitive dysfunction: Pathophysiology, diagnosis, and treatment. Vet Clin North Am Small Anim Pract. 49:477–499. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Esquerda-Canals G, Montoliu-Gaya L, Güell-Bosch J and Villegas S: Mouse models of Alzheimer's Disease. J Alzheimers Dis. 57:1171–1183. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Puzzo D, Gulisano W, Palmeri A and Arancio O: Rodent models for Alzheimer's disease drug discovery. Expert Opin Drug Discov. 10:703–711. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hefti F, Dravid A and Hartikka J: Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293:305–311. 1984.PubMed/NCBI View Article : Google Scholar | |
|
Washida K, Hattori Y and Ihara M: Animal models of chronic cerebral hypoperfusion: From mouse to primate. Int J Mol Sci. 20(6176)2019.PubMed/NCBI View Article : Google Scholar | |
|
Yi J, Liu BY and Cai GX: Study on effect of Ultra-powder Liuwei Dihuang decoction on recognize and bFGF in Alzheime's disease rats bFGF. Chin J Exp Tradit Med Formulae. 17:139–142. 2011. | |
|
Chen HF, Mo YS and Yang C: Protective effect and mechanism of quercetin on hippocampal neurons in IBO-injured rats. Tradit Chin Drug Res Clin Pharmacol. 29:552–556. 2018. | |
|
Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR and de la Monte SM: Intracerebral Streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis. 9:13–33. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Wang C, Cai Z, Wang W, Wei M, Si X, Shang Y, Yang Z, Li T, Guo H and Li S: Piperine regulates glycogen synthase kinase-3β-related signaling and attenuates cognitive decline in D-galactose-induced aging mouse model. J Nutr Biochem. 75(108261)2020.PubMed/NCBI View Article : Google Scholar | |
|
Mustafa HN: Neuro-amelioration of cinnamaldehyde in aluminum-induced Alzheimer's disease rat model. J Histotechnol. 43:11–20. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Song XY, Hu JF, Chu SF, Zhang Z, Xu S, Yuan YH, Han N, Liu Y, Niu F, He X and Chen NH: Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats. Eur J Pharmacol. 710:29–38. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Haider S, Tabassum S and Perveen T: Scopolamine-induced greater alterations in neurochemical profile and increased oxidative stress demonstrated a better model of dementia: A comparative study. Brain Res Bull. 127:234–247. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zangerolamo L, Vettorazzi JF, Solon C, Bronczek GA, Engel DF, Kurauti MA, Soares GM, Rodrigues KS, Velloso LA, Boschero AC, et al: The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model. Mol Cell Endocrinol. 521(111116)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liu RM: Aging, cellular senescence, and Alzheimer's Disease. Int J Mol Sci. 23(1989)2022.PubMed/NCBI View Article : Google Scholar | |
|
Stern Y: Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 11:1006–1012. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Leuti A, Fazio D, Fava M, Piccoli A, Oddi S and Maccarrone M: Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev. 159:133–169. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kälin S, Heppner FL, Bechmann I, Prinz M, Tschöp MH and Yi CX: Hypothalamic innate immune reaction in obesity. Nat Rev Endocrinol. 11:339–351. 2015.PubMed/NCBI View Article : Google Scholar | |
|
de Git KC and Adan RA: Leptin resistance in diet-induced obesity: The role of hypothalamic inflammation. Obes Rev. 16:207–224. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Boccardi V, Murasecco I and Mecocci P: Diabetes drugs in the fight against Alzheimer's disease. Ageing Res Rev. 54(100936)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kellar D and Craft S: Brain insulin resistance in Alzheimer's disease and related disorders: Mechanisms and therapeutic approaches. Lancet Neurol. 19:758–766. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Campbell JM, Stephenson MD, de Courten B, Chapman I, Bellman SM and Aromataris E: Metformin use associated with reduced risk of dementia in patients with diabetes: A systematic review and Meta-Analysis. J Alzheimers Dis. 65:1225–1236. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Briggs R, Kennelly SP and O'Neill D: Drug treatments in Alzheimer's disease. Clin Med (Lond). 16:247–253. 2016.PubMed/NCBI View Article : Google Scholar |
